Sign Up to like & get
recommendations!
0
Published in 2019 at "Urologia Internationalis"
DOI: 10.1159/000502664
Abstract: Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3…
read more here.
Keywords:
lymphoma kinase;
associated renal;
crizotinib associated;
anaplastic lymphoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8445-16
Abstract: Crizotinib, which is effective in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer, is sometimes associated with the generation of complex renal cysts. A 56-year-old man with ALK positive adenocarcinoma received crizotinib.…
read more here.
Keywords:
associated complex;
crizotinib associated;
switching alectinib;
crizotinib ... See more keywords